<?xml version="1.0"?>
<rss version="2.0" xmlns:prism="http://purl.org/rss/1.0/modules/prism/">
  <channel>
    <title>JAMA: Cancer Screening Topic Collection</title>
    <link>http://jama.jamanetwork.com/</link>
    <description>
    </description>
    <language>en-us</language>
    <pubDate>Wed, 08 May 2013 00:00:00 GMT</pubDate>
    <lastBuildDate>Tue, 07 May 2013 22:44:57 GMT</lastBuildDate>
    <generator>Silverchair</generator>
    <managingEditor>editor@jama.jamanetwork.com</managingEditor>
    <webMaster>webmaster@jama.jamanetwork.com</webMaster>
    <item>
      <title>Severing the Link Between Coverage Policy and the US Preventive Services Task Force Severing the Coverage Policy–USPSTF Link </title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1679803</link>
      <pubDate>Wed, 08 May 2013 00:00:00 GMT</pubDate>
      <author>Woolf SH, Campos-Outcalt D. </author>
      <description>&lt;span class="paragraphSection"&gt;Concern is growing over a potential flaw in the Affordable Care Act (ACA): the mandate to offer first-dollar coverage for all preventive services that receive A and B recommendations from the US Preventive Services Task Force (USPSTF). The USPSTF, an independent panel established during the Reagan administration in 1984, is composed of clinicians who specialize in the critical appraisal of evidence and make recommendations on clinical preventive services that are graded by the strength of the evidence: A and B recommendations when there is compelling evidence that benefits outweigh harms, C recommendations when the net benefit is modest, D recommendations when there is evidence of net harm or no benefit, and I statements when there is insufficient evidence to make a recommendation.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">18</prism:number>
      <prism:startingPage xmlns:prism="prism">1899</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1900</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.3448</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1679803</guid>
    </item>
    <item>
      <title>From  JAMA  ’s Daily News Site</title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1685856</link>
      <pubDate>Wed, 08 May 2013 00:00:00 GMT</pubDate>
      <author />
      <description />
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">18</prism:number>
      <prism:startingPage xmlns:prism="prism">1884</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1884</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.4959</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1685856</guid>
    </item>
    <item>
      <title>Lung Cancer Screening</title>
      <link>http://jama.jamanetwork.com/article.aspx?articleID=1685860</link>
      <pubDate>Wed, 08 May 2013 00:00:00 GMT</pubDate>
      <author>Boiselle PM, Lynm C, Livingston EH. </author>
      <description>&lt;span class="paragraphSection"&gt;Lung cancer is the international leading cause of cancer deaths. Tobacco use is the principal risk factor for lung cancer and accounts for at least 85% of all lung cancers. Until recently, no screening test had been shown to be effective in reducing deaths associated with this disease.&lt;/span&gt;</description>
      <prism:volume xmlns:prism="prism">309</prism:volume>
      <prism:number xmlns:prism="prism">18</prism:number>
      <prism:startingPage xmlns:prism="prism">1948</prism:startingPage>
      <prism:endingPage xmlns:prism="prism">1948</prism:endingPage>
      <prism:doi xmlns:prism="prism">10.1001/jama.2013.4324</prism:doi>
      <guid>http://jama.jamanetwork.com/article.aspx?articleID=1685860</guid>
    </item>
  </channel>
</rss>